Intersouth Partners, a venture capital firm that provides entrepreneurs with early stage capital, has named Katrin Burt and James Rosen as partners.
Burt (pictured) has been an associate of the firm since 2007 as a member of the technology team. She joined Intersouth in 2004 as an analyst, working with the firm’s investment team on the analysis of potential new investments and the growth of Intersouth’s existing portfolio companies.
Burt joined Intersouth from HSBC, where she was a foreign exchange trader in London, managed portfolios of treasury products and equities in Tokyo and eventually moved to a business development role managing the annual operating plan for the bank’s global markets Europe division.
Rosen has been an associate of the firm since 2007 as a member of the life sciences team. He joined Intersouth as an investment intern in 2005 while completing his graduate degrees. Prior to graduate school, he worked at the UNC Lineberger Comprehensive Cancer Center. He was an equity research analyst at Brean Murray covering biopharmaceuticals, genomics, generics, drug delivery and medical device companies.
“Jimmy and Katrin have been an integral part of the Intersouth team since joining the firm in 2005,” says Intersouth managing partner Dennis Dougherty. “Entrepreneurs within the community rely on them as trusted advisors with a strong work ethic and the highest integrity. As partners, they will continue to seek out the strongest management teams and the most exciting start-up opportunities for Intersouth to partner with and support.”
As partners, Burt and Rosen will continue to source investments, perform due diligence and manage portfolio companies. Intersouth has 12 investment professionals on its team, covering both life science and technology investments for the firm.
